Application of bacillus megaterium for subclinical mastitis in cows
Abstract
The problem of treatment of subclinical mastitis often arises after calving, especially in cows of the first lactation. The paper presents the results of the therapeutic effect of Bacillus megaterium in subclinical mastitis in cows.
The aim of the research. To determine the effect of Bacillus megaterium on the microflora of the gastrointestinal tract and colonies of microorganisms isolated from subclinical mastitis in cows.
Materials and methods. The research was conducted in a dairy farm growing Holstein. Cows with subclinical mastitis of the experimental groups were given concentrated feed with the addition of Bacillus megaterium (1 × 109 CFU/g) at a dose of 15–35 g per animal. The control group of cows was given the usual diet for dairy cows. The experiment lasted 30 days.
Results. The use of Bacillus megaterium (1 × 109 CFU/g) at a dose of 35 g per animal had a pronounced effect on the microflora of the gastrointestinal tract of cows. The amount of Lactobacillus sp. was 67 % higher and Bifidobacterium 58 % higher than the control. In addition, the level of opportunistic pathogens on Escherichia coli decreased by 45 %, Clostridium by 27 %, Enterobacteriaceae and Staphylococcus by 75 %, and Candida by 80 % compared to controls. The amount of microflora in milk decreased by 40.2 % and the number of somatic cells by 87.9 %.
Conclusions. The therapeutic efficacy of Bacillus megaterium (1 × 109 CFU/g) at a dose of 35 g per animal for 30 days in subclinical mastitis has been proven. After treatment, the amount of microflora in cow's milk decreased by 40.2 % and the number of somatic cells by 87.9 %.
A positive effect on the microflora of the gastrointestinal tract of cows, where the number of Lactobacillus sp. increased by 67 % and Bifidobacterium by 58 %. The level of opportunistic pathogenic microflora decreased by Escherichia coli – by 45 %, Clostridium – by 27 %, Enterobacteriaceae and Staphylococcus – by 75 %, Candida – by 80 %, compared to the control.
Downloads
References
Sepúlveda-Varas, P., Proudfoot, K. L., Weary, D. M., von Keyserlingk, M. A. G. (2016). Changes in behaviour of dairy cows with clinical mastitis. Applied Animal Behaviour Science, 175, 8–13. doi: http://doi.org/10.1016/j.applanim.2014.09.022
Wang, Y., Nan, X., Zhao, Y., Jiang, L., Wang, M., Wang, H. et. al. (2021). Rumen microbiome structure and metabolites activity in dairy cows with clinical and subclinical mastitis. Journal of Animal Science and Biotechnology, 12 (1). doi: http://doi.org/10.1186/s40104-020-00543-1
Bardhan, D. (2013). Estimates of economic losses due to clinical mastitis in organized dairy farms. Indian Journal of Dairy Science, 66, 168–172.
Shkromada, O., Palii, A., Palii, A., Skliar, O., Dudchenko, Y., Necherya, T. (2019). Improvement of milk quality for micro-climate formation on cattle farms. Bulletin of Sumy National Agrarian University. The Series: Veterinary Medicine, 4 (47), 43–49. doi: http://doi.org/10.32845/bsnau.vet.2019.4.7
Sinha, M. K., Thombare, N. N., Mondal, B. (2014). Subclinical Mastitis in Dairy Animals: Incidence, Economics, and Predisposing Factors. The Scientific World Journal, 2014, 1–4. doi: http://doi.org/10.1155/2014/523984
Clemente, J. C., Manasson, J., Scher, J. U. (2018). The role of the gut microbiome in systemic inflammatory disease. BMJ, j5145. doi: http://doi.org/10.1136/bmj.j5145
Jost, T., Lacroix, C., Braegger, C., Chassard, C. (2013). Assessment of bacterial diversity in breast milk using culture-dependent and culture-independent approaches. British Journal of Nutrition, 110 (7), 1253–1262. doi: http://doi.org/10.1017/s0007114513000597
Ma, C., Sun, Z., Zeng, B., Huang, S., Zhao, J., Zhang, Y. et. al. (2018). Cow-to-mouse fecal transplantations suggest intestinal microbiome as one cause of mastitis. Microbiome, 6 (1). doi: http://doi.org/10.1186/s40168-018-0578-1
Shively, C. A., Register, T. C., Appt, S. E., Clarkson, T. B., Uberseder, B., Clear, K. Y. J. et. al. (2018). Consumption of Mediterranean versus Western Diet Leads to Distinct Mammary Gland Microbiome Populations. Cell Reports, 25 (1), 47–56.e3. doi: http://doi.org/10.1016/j.celrep.2018.08.078
Bhutto, A. L., Murray, R. D., Woldehiwet, Z. (2012). California mastitis test scores as indicators of subclinical intra-mammary infections at the end of lactation in dairy cows. Research in Veterinary Science, 92 (1), 13–17. doi: http://doi.org/10.1016/j.rvsc.2010.10.006
Prescott, S. C., Breed, R. S. (1910). The determination of the number of body cells in milk by a direct method. American Journal of Public Hygiene, 20, 662–640. Available at: https://pubmed.ncbi.nlm.nih.gov/19599514/
Das, D., Panda, S. K., Jena, B., Sahoo, A. K. (2018). Economic Impact of Subclinical and Clinical Mastitis in Odisha, India. International Journal of Current Microbiology and Applied Sciences, 7 (3), 3651–3654. doi: http://doi.org/10.20546/ijcmas.2018.703.422
Abebe, R., Hatiya, H., Abera, M., Megersa, B., Asmare, K. (2016). Bovine mastitis: prevalence, risk factors and isolation of Staphylococcus aureus in dairy herds at Hawassa milk shed, South Ethiopia. BMC Veterinary Research, 12 (1). doi: http://doi.org/10.1186/s12917-016-0905-3
Romero, J., Benavides, E., Meza, C. (2018). Assessing Financial Impacts of Subclinical Mastitis on Colombian Dairy Farms. Frontiers in Veterinary Science, 5. doi: http://doi.org/10.3389/fvets.2018.00273
Kalińska, A., Jaworski, S., Wierzbicki, M., Gołębiewski, M. (2019). Silver and Copper Nanoparticles – An Alternative in Future Mastitis Treatment and Prevention? International Journal of Molecular Sciences, 20 (7), 1672. doi: http://doi.org/10.3390/ijms20071672
Copyright (c) 2021 Yaroslav Tytukh, Yurii Musiienko, Natalia Grebenik
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
